Direct License. In the event that this Agreement terminates, any sublicense granted under the terms of Section 2.02 hereunder shall, upon the written request of the sublicensee, become a direct license between PDL and that sublicensee so long as the (a) sublicense does not impose obligations on PDL beyond those set forth in this Agreement, and (b) sublicensee is not in breach of its sublicense agreement or, mutatis mutandis, the terms of this Agreement.
Appears in 4 contracts
Samples: Patent License Agreement (PDL Biopharma, Inc.), Patent License Agreement (PDL Biopharma, Inc.), Patent License Agreement (Medimmune Inc /De)
